PITTSBURGH — Giant Eagle has acquired Rx21 Specialty Pharmacy, a move that will allow it to provide enhanced services to hepatitis C and organ transplant patients and providers under its Giant Eagle Specialty Pharmacy, the retailer said.
“We greatly value the expertise gained with the new acquisition of Rx21, particularly at a time when two significant new hepatitis C treatments are becoming available,” Brett Merrell, senior vice president of health and wellness of Giant Eagle, in a statement.
The Food and Drug Administration recently approved Olysio for use as a treatment for those with hepatitis C, and is expected to approve a similar new drug, sofosbuvir.
Approximately 3.2 million people in the U.S. have hepatitis C, a viral condition that causes inflammation of the liver and can lead to permanent liver damage, liver cancer, liver failure and cirrhosis, according to the Centers for Disease Control.
Read more: Giant Eagle to Offer Free Prescription Delivery
In addition to access to Rx21's expertise and clinical support, Giant Eagle Specialty Pharmacy customers suffering from Hepatitis C and transplant conditions will have 24-hour-a-day access to pharmacists ready to provide counsel on medication management.
| Suggested Categories | More from Supermarketnews |
 |
|
|
|